Priya Vart

23.4k total citations · 2 hit papers
113 papers, 2.3k citations indexed

About

Priya Vart is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Priya Vart has authored 113 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Nephrology, 28 papers in Endocrinology, Diabetes and Metabolism and 24 papers in Surgery. Recurrent topics in Priya Vart's work include Chronic Kidney Disease and Diabetes (30 papers), Diabetes Treatment and Management (25 papers) and Dialysis and Renal Disease Management (12 papers). Priya Vart is often cited by papers focused on Chronic Kidney Disease and Diabetes (30 papers), Diabetes Treatment and Management (25 papers) and Dialysis and Renal Disease Management (12 papers). Priya Vart collaborates with scholars based in Netherlands, United States and United Kingdom. Priya Vart's co-authors include Kashif Shafique, Saira Saeed Mirza, Fauzia Imtiaz, Ron T. Gansevoort, Hiddo J.L. Heerspink, Ute Bültmann, Sijmen A. Reijneveld, Niels Jongs, Glenn M. Chertow and David C. Wheeler and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and American Journal of Clinical Nutrition.

In The Last Decade

Priya Vart

104 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population

2012 476 citations Priya Vart et al. profile →
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

2023 132 citations Brendon L. Neuen, Hiddo J.L. Heerspink et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Priya Vart Netherlands	26	567	496	456	422	321	113	2.3k
Jiaxiao Shi United States	24	250 0.4×	217 0.4×	606 1.3×	354 0.8×	321 1.0×	101	2.3k
Chi-Pang Wen Taiwan	14	466 0.8×	932 1.9×	540 1.2×	276 0.7×	463 1.4×	14	2.5k
Simon Ogston United Kingdom	31	562 1.0×	248 0.5×	326 0.7×	421 1.0×	599 1.9×	64	2.6k
Esther M. Briganti Australia	23	537 0.9×	1.1k 2.3×	476 1.0×	347 0.8×	382 1.2×	38	2.8k
Nawar Shara United States	28	287 0.5×	201 0.4×	360 0.8×	353 0.8×	472 1.5×	120	2.4k
Shih‐Chieh Shao Taiwan	24	416 0.7×	178 0.4×	299 0.7×	377 0.9×	257 0.8×	94	2.3k
Chengshi Jin United States	27	222 0.4×	429 0.9×	172 0.4×	533 1.3×	282 0.9×	77	2.8k
Yalçın Solak Türkiye	33	290 0.5×	1.3k 2.6×	555 1.2×	571 1.4×	294 0.9×	140	3.2k
Hajeong Lee South Korea	31	286 0.5×	1.4k 2.9×	424 0.9×	603 1.4×	551 1.7×	257	3.7k
Rhonda L. Bohn United States	28	207 0.4×	274 0.6×	729 1.6×	695 1.6×	272 0.8×	83	3.5k

Countries citing papers authored by Priya Vart

Since Specialization

Citations

This map shows the geographic impact of Priya Vart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priya Vart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priya Vart more than expected).

Fields of papers citing papers by Priya Vart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priya Vart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priya Vart. The network helps show where Priya Vart may publish in the future.

Co-authorship network of co-authors of Priya Vart

This figure shows the co-authorship network connecting the top 25 collaborators of Priya Vart. A scholar is included among the top collaborators of Priya Vart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priya Vart. Priya Vart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bakker, W, Hiddo J.L. Heerspink, Niels Jongs, et al.. (2025). Effects of Dapagliflozin on Health-Related Quality of Life in Patients with CKD. Journal of the American Society of Nephrology. 37(1). 101–109. 1 indexed citations

Casteleijn, Niek F., et al.. (2025). The long-term effect of tolvaptan treatment on kidney function and volume in patients with ADPKD. Nephrology Dialysis Transplantation. 40(9). 1764–1774. 1 indexed citations

Delanaye, Pierre, Priya Vart, Jürgen Floege, & Carmine Zoccali. (2025). Age-adapted versus age-independent eGFR thresholds to diagnose CKD: integrating the debate and charting a balanced path forward. Clinical Kidney Journal. 18(11). sfaf328–sfaf328.

Yang, Changyuan, et al.. (2025). Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox. Nephrology Dialysis Transplantation.

Luo, Li, Lyanne M. Kieneker, Roemer J. Janse, et al.. (2024). An increase in albuminuria is associated with a higher incidence of malignancies. Clinical Kidney Journal. 17(3). sfae009–sfae009. 2 indexed citations

Messchendorp, A. Lianne, Jan‐Stephan Sanders, Alferso C Abrahams, et al.. (2024). Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients. Viruses. 16(1). 114–114. 4 indexed citations

Groningen, Marian C. Clahsen‐van, Brenda C. M. de Winter, Priya Vart, et al.. (2024). Multicenter, Real‐World Clinical Evaluation of Alemtuzumab and Anti‐Thymocyte Globulin for Severe Acute T Cell‐Mediated Kidney Transplant Rejection. Clinical Transplantation. 38(12). e70046–e70046.

Luo, Li, Lyanne M. Kieneker, Bert van der Vegt, et al.. (2023). Urinary albumin excretion and cancer risk: the PREVEND cohort study. Nephrology Dialysis Transplantation. 38(12). 2723–2732. 8 indexed citations

Luo, Li, Priya Vart, Lyanne M. Kieneker, et al.. (2023). Mediators of the association between albuminuria and incident cancer: the PREVEND study. Clinical Kidney Journal. 17(1). sfad295–sfad295. 1 indexed citations

10.

Neuen, Brendon L., Hiddo J.L. Heerspink, Priya Vart, et al.. (2023). Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria. Circulation. 149(6). 450–462. 132 indexed citations breakdown →

11.

Vart, Priya, Muthiah Vaduganathan, Niels Jongs, et al.. (2022). Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes. Clinical Journal of the American Society of Nephrology. 17(12). 1754–1762. 36 indexed citations

12.

Vart, Priya, Raphaël Duivenvoorden, Casper Franssen, et al.. (2022). Preparing European Nephrology for the next pandemic: lessons from the ERACODA collaboration. Nephrology Dialysis Transplantation. 38(3). 575–582. 2 indexed citations

13.

Vart, Priya, David Z.I. Cherney, Glenn M. Chertow, et al.. (2022). Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial. Diabetologia. 65(7). 1085–1097. 35 indexed citations

14.

Heijden, Olivier W.H. van der, Priya Vart, Laura Rodwell, et al.. (2022). Timing of cardiac surgery during pregnancy: a patient-level meta-analysis. European Heart Journal. 43(29). 2801–2811. 18 indexed citations

15.

Chertow, Glenn M., Priya Vart, Niels Jongs, et al.. (2021). Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease. UCL Discovery (University College London). 80 indexed citations

16.

Eerden, Anke W. van der, Vincent Perlbarg, Priya Vart, et al.. (2021). Traumatic Cerebral Microbleeds in the Subacute Phase Are Practical and Early Predictors of Abnormality of the Normal-Appearing White Matter in the Chronic Phase. American Journal of Neuroradiology. 42(5). 861–867. 2 indexed citations

17.

Eerden, Anke W. van der, Thomas L. A. van den Heuvel, Marnix C. Maas, et al.. (2021). The radiological interpretation of possible microbleeds after moderate or severe traumatic brain injury: a longitudinal study. Neuroradiology. 64(6). 1145–1156. 2 indexed citations

18.

Soler, María José, Marlies Noordzij, Daniel Abramowicz, et al.. (2021). Renin-Angiotensin System Blockers and the Risk of COVID-19–Related Mortality in Patients with Kidney Failure. Clinical Journal of the American Society of Nephrology. 16(7). 1061–1072. 6 indexed citations

19.

Barlas, Raphae S., Priya Vart, Joao H. Bettencourt‐Silva, et al.. (2020). Association of chronic kidney disease with outcomes in acute stroke. Acta Neurologica Belgica. 121(5). 1241–1246. 3 indexed citations

20.

Vart, Priya, Raphae S. Barlas, Joao H. Bettencourt‐Silva, et al.. (2019). Estimated glomerular filtration rate and risk of poor outcomes after stroke. European Journal of Neurology. 26(12). 1455–1463. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact